Dublin, June 21, 2019 (GLOBE NEWSWIRE) -- The "Protein Stability Analysis Market by Product (Assay & Reagent, Instrument), Technique (Chromatography, Spectroscopy, SPR, DSF), End User (Pharmaceutical & Biotech Companies, Research Institute) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global protein stability analysis market is projected to reach USD 2,102.7 million in 2024 from USD 1,186.9 million in 2018, at CAGR of 10.0% during the forecast period.
The growing adoption of open innovation models in pharmaceutical and biotechnology companies and increasing pharmaceutical outsourcing are the key factors driving the growth of the protein stability analysis market. However, the high cost of protein stability analysis instruments may restrain the growth of the market to a certain extent during the forecast period.
On the basis of products, the protein stability analysis market is divided into reagents & assay kits, instruments, consumables & accessories, and software. Reagents and assay kits accounted for the largest share of the protein stability analysis market in 2018. The large share of this market segment can be attributed to the high consumption of reagents and assay kits in protein stability analysis techniques, increasing protein pharmaceutical R&D, and increased government funding for life science research.
On the basis of technique, the protein stability analysis market is segmented into chromatography, spectroscopy, surface plasma resonance imaging (SPRI), differential scanning calorimetry (DSC), differential scanning fluorimetry (DSF), and other techniques. In 2018, the chromatography segment dominated this market due to factors such as the high usage of HPLC and size-exclusion chromatography for protein stability and aggregate analysis in drug discovery and development for ensuring drug safety. By end user, the global protein stability analysis market is segmented into pharmaceutical and biotechnology companies, contract research organization, and academic & research institutes.
Pharmaceutical & biotechnology companies accounted for the largest share of the protein stability analysis market in 2018. The large share of this segment is primarily due to the extensive use of protein stability analysis in pharmaceutical & biotechnology companies for drug discovery applications. Stringent regulations for pharmaceutical drug development and manufacturing, the utilization of the quality-by-design approach in drug discovery & development, and increasing public-private research investments & funding for drug development are also supporting the adoption of protein stability analysis instruments in this end-user segment.
Market Dynamics
Drivers
- Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
- Increasing Pharmaceutical Outsourcing
Restraints
- High Cost of Protein Stability Analysis Instruments
Opportunities
- Emerging Markets
Challenges
- Shortage of Skilled Professionals
Companies Mentioned
- Agilent Technologies, Inc.
- Enzo Biochem, Inc.
- General Electric Healthcare
- Horiba, Ltd
- Malvern Panalytical Ltd (Spectris company)
- NanoTemper Technologies
- Perkinelmer, Inc.
- Setaram Instrumentation
- Shimadzu Corporation
- Spectris PLC
- Thermo Fisher Scientific
- Unchained Labs
- Waters Corporation
For more information about this report visit https://www.researchandmarkets.com/r/dnkj8b
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.